Abstract
According to the European Pharmacopoeia sterility testing of products includes an incubation time of 14 days in thioglycollate medium and soya-bean casein medium. In this case a large period of time is needed for product testing. So we designed a study to evaluate an alternative method for sterility testing. The aim of this study was to reduce the incubation time for the routinely produced products in our tissue bank (cornea and amnion grafts) by obtaining the same detection limit, accurateness and recovery rates as the reference method described in the European Pharmacopoeia. The study included two steps of validation. Primary validation compared the reference method with the alternative method. Therefore eight bacterial and two fungi test strains were tested at their preferred milieu. A geometric dilution series from 10 to 0.625 colony forming unit per 10 ml culture media was used. Subsequent to the evaluation the second part of the study started including the validation of the fertility of the culture media and the parallel testing of the two methods by investigating products. For this purpose two product batches were tested in three independent runs. Concerning the validation we could not find any aberration between the alternative and the reference method. In addition, the recovery rate of each microorganism was between 83.33 and 100 %. The alternative method showed non-inferiority regarding accuracy to the reference method. Due to this study we reduced the sterility testing for cornea and amniotic grafts to 9 days.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Adds PJ, Hunt C, Hartley S (2001) Bacterial contamination of amniotic membrane. Br J Ophthalmol 85:228–230
Aghayan HR, Goodarzi P, Baradaran-Rafii A, Larijani B, Moradabadi L, Rahim F, Arjmand B (2012) Bacterial contamination of amniotic membrane in a tissue bank from Iran. Cell Tissue Bank 14:401–406
Buhimschi IA, Jabr M, Buhimschi CS, Petkova AP, Weiner CP, Saed GM (2004) The novel antimicrobial peptide beta3-defensin is produced by the amnion: a possible role of the fetal membranes in innate immunity of the amniotic cavity. Am J Obstet Gynecol 191:1678–1687
Davis JW (1910) Skin transplantation with a review of 550 cases at the Johns Hopkins Hospital. Johns Hopkins Med J 15:307
de By TM, Parker R, Delmo Walter EM, Hetzer R (2012) Cardiovascular tissue banking in Europe. HSR Proc Intensive Care Cardiovasc Anesth 4:251–260
Dichtl M, Gabriel C, Hennerbichler S, Seitz B, Priglinger SG (2010) EU konformes Hornhautbanking - eine Bestandsaufnahme Hornhautbank Linz. Spektrum der Augenheilkunde 24:166–173
Dua HS, Gomes JA, King AJ, Maharajan VS (2004) The amniotic membrane in ophthalmology. Surv Ophthalmol 49:51–77
Eastlund T (2006) Bacterial infection transmitted by human tissue allograft transplantation. Cell Tissue Bank 7:147–166
Eastlund T, Strong DM (2003) Infectious disease transmission through tissue transplantation. Adv Tissue Bank 7: 51–131. In: Phillips GO (ed). World Scientific Publishing Company, Singapore
Edwards M, Clover GM, Brookes N, Pendergrast D, Chaulk J, McGhee CN (2002) Indications for corneal transplantation in New Zealand: 1991–1999. Cornea 21:152–155
European Directorate for the Quality of Medicines & HealthCare (2010) European Pharmacopoeia, 7th edn, vol 1
Farrell PL, Fan JT, Smith RE, Trousdale MD (1991) Donor cornea bacterial contamination. Cornea 10:381–386
King AE, Paltoo A, Kelly RW, Sallenave JM, Bocking AD, Challis JR (2007) Expression of natural antimicrobials by human placenta and fetal membranes. Placenta 28:161–169
Lee SH, Tseng SC (1997) Amniotic membrane transplantation for persistent epithelial defects with ulceration. Am J Ophthalmol 123:303–312
Marangon FB, Alfonso EC, Miller D, Remonda NM, Muallem MS, Tseng SC (2004) Incidence of microbial infection after amniotic membrane transplantation. Cornea 23:264–269
Matthews RN, Faulk WP, Bennett JP (1982) A review of the role of amniotic membranes in surgical practice. Obstet Gynecol Annu 11:31–58
McDonald CP, Rogers A, Cox M, Smith R, Roy A, Robbins S, Hartley S, Barbara JA, Rothenberg S, Stutzman L, Widders G (2002) Evaluation of the 3D BacT/ALERT automated culture system for the detection of microbial contamination of platelet concentrates. Transfus Med 12:303–309
Montag-Lessing T, Stormer M, Schurig U, Brachert J, Bubenzer M, Sicker U, Beshir R, Spreitzer I, Loschner B, Bache C, Becker B, Schneider CK (2010) Problems in microbial safety of advanced therapy medicinal products. Squaring the circle. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 53:45–51
Nussbaumer W, Allerstorfer D, Grabmer C, Rheinschmidt M, Lin L, Schonitzer D, Lass-Florl C (2007) Prevention of transfusion of platelet components contaminated with low levels of bacteria: a comparison of bacteria culture and pathogen inactivation methods. Transfusion 47:1125–1133
Pardos GJ, Gallagher MA (1982) Microbial contamination of donor eyes. A retrospective study. Arch Ophthalmol 100:1611–1613
Parveen S, Kaur S, David SA, Kenney JL, McCormick WM, Gupta RK (2011) Evaluation of growth based rapid microbiological methods for sterility testing of vaccines and other biological products. Vaccine 29:8012–8023
Rommel N, Rohleder NH, Gabriel C, Hennerbichler S, Bauer F, Mucke T, Kolk A, Loeffelbein DJ, Wolff KD, Kesting MR (2013) Secondary correction of posttraumatic orbital wall adhesions by membranes laminated with amniotic membrane. Br J Oral Maxillofac Surg 51:e224–e229
Schmidt M, Karakassopoulos A, Burkhart J, Deitenbeck R, Asmus J, Muller TH, Weinauer F, Seifried E, Walther-Wenke G (2007) Comparison of three bacterial detection methods under routine conditions. Vox Sang 92:15–21
Schroeter J, Wilkemeyer I, Schiller RA, Pruss A (2012) Validation of the microbiological testing of tissue preparations using the BACTEC blood culture system. Transfus Med Hemother 39:387–390
Von GA, Weinstein J (1971) Pathogenic significance of Pseudomonas fluorescens and Pseudomonas putida. Yale J Biol Med 44:265–273
Wang S, Zinderman C, Wise R, Braun M (2007) Infections and human tissue transplants: review of FDA MedWatch reports 2001–2004. Cell Tissue Bank 8:211–219
Acknowledgments
We would like to thank Anja Peterbauer-Scherb for her input during manuscript preparation.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Suessner, S., Hennerbichler, S., Schreiberhuber, S. et al. Validation of an alternative microbiological method for tissue products. Cell Tissue Bank 15, 277–286 (2014). https://doi.org/10.1007/s10561-014-9455-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10561-014-9455-8